These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12588953)

  • 1. Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men.
    Couillard C; Vohl MC; Engert JC; Lemieux I; Houde A; Almeras N; Prud'homme D; Nadeau A; Despres JP; Bergeron J
    J Lipid Res; 2003 May; 44(5):986-93. PubMed ID: 12588953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral obesity and hyperinsulinemia modulate the impact of the microsomal triglyceride transfer protein -493G/T polymorphism on plasma lipoprotein levels in men.
    St-Pierre J; Lemieux I; Miller-Felix I; Prud'homme D; Bergeron J; Gaudet D; Nadeau A; Despres JP; Vohl MC
    Atherosclerosis; 2002 Feb; 160(2):317-24. PubMed ID: 11849654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of polymorphism (RFLP-sstI) at the apolipoprotein C-III gene locus on the lipoprotein metabolism and insulin resistance in essential hypertensive patients. Interaction between gender and genetic polymorphism.
    Espino-Montoro A; Barrios-Artillo M; López-Chozas JM; Cayuela A; Stiefel P; Villar J
    Nutr Metab Cardiovasc Dis; 2003 Aug; 13(4):194-201. PubMed ID: 14650351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the FABP2 A54T mutation on triglyceride metabolism of viscerally obese men.
    Berthier MT; Couillard C; Prud'homme D; Nadeau A; Bergeron J; Tremblay A; Després JP; Vohl MC
    Obes Res; 2001 Nov; 9(11):668-75. PubMed ID: 11707533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.
    Tchernof A; Lamarche B; Prud'Homme D; Nadeau A; Moorjani S; Labrie F; Lupien PJ; Després JP
    Diabetes Care; 1996 Jun; 19(6):629-37. PubMed ID: 8725863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France.
    Dallongeville J; Meirhaeghe A; Cottel D; Fruchart JC; Amouyel P; Helbecque N
    Atherosclerosis; 2000 May; 150(1):149-57. PubMed ID: 10781646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
    Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
    Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study.
    Russo GT; Meigs JB; Cupples LA; Demissie S; Otvos JD; Wilson PW; Lahoz C; Cucinotta D; Couture P; Mallory T; Schaefer EJ; Ordovas JM
    Atherosclerosis; 2001 Sep; 158(1):173-81. PubMed ID: 11500189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests.
    Waterworth DM; Ribalta J; Nicaud V; Dallongeville J; Humphries SE; Talmud P
    Circulation; 1999 Apr; 99(14):1872-7. PubMed ID: 10199885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity.
    Berthier MT; Houde A; Bergeron J; Prud'homme D; Després JP; Vohl MC
    J Hum Genet; 2003; 48(7):367-73. PubMed ID: 12851844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial triglyceride response in visceral obesity in men.
    Couillard C; Bergeron N; Prud'homme D; Bergeron J; Tremblay A; Bouchard C; Mauriège P; Després JP
    Diabetes; 1998 Jun; 47(6):953-60. PubMed ID: 9604874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients.
    Fauvel J; Bonnet E; Ruidavets JB; Ferrières J; Toffoletti A; Massip P; Chap H; Perret B
    AIDS; 2001 Dec; 15(18):2397-406. PubMed ID: 11740190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The apoB-100 gene EcoRI polymorphism influences the relationship between features of the insulin resistance syndrome and the hyper-apoB and dense LDL phenotype in men.
    Vohl MC; Tchernof A; Dionne FT; Moorjani S; Prud'homme D; Bouchard C; Nadeau A; Lupien PJ; Després JP
    Diabetes; 1996 Oct; 45(10):1405-11. PubMed ID: 8826978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MspI polymorphism of the apolipoprotein A-II gene as a modulator of the dyslipidemic state found in visceral obesity.
    Vohl MC; Lamarche B; Bergeron J; Moorjani S; Prud'homme D; Nadeau A; Tremblay A; Lupien PJ; Bouchard C; Després JP
    Atherosclerosis; 1997 Feb; 128(2):183-90. PubMed ID: 9050775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions.
    Fredenrich A; Giroux LM; Tremblay M; Krimbou L; Davignon J; Cohn JS
    J Lipid Res; 1997 Jul; 38(7):1421-32. PubMed ID: 9254067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity.
    Chan DC; Watts GF; Barrett PH; Mamo JC; Redgrave TG
    Clin Chem; 2002 Feb; 48(2):278-83. PubMed ID: 11805008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia.
    Groenendijk M; Cantor RM; Blom NH; Rotter JI; de Bruin TW; Dallinga-Thie GM
    J Lipid Res; 1999 Jun; 40(6):1036-44. PubMed ID: 10357835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the insulin response element of APOC-III gene promoter influence the correlation between insulin and triglycerides or triglyceride-rich lipoproteins in humans.
    Dallongeville J; Meirhaeghe A; Cottel D; Fruchart JC; Amouyel P; Helbecque N
    Int J Obes Relat Metab Disord; 2001 Jul; 25(7):1012-7. PubMed ID: 11443500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the SstI polymorphism at the apolipoprotein C-III gene locus on the plasma low-density-lipoprotein-cholesterol response to dietary monounsaturated fat.
    López-Miranda J; Jansen S; Ordovas JM; Salas J; Marín C; Castro P; Ostos MA; Cruz G; López-Segura F; Blanco A; Jiménez-Perepérez J; Pérez-Jiménez F
    Am J Clin Nutr; 1997 Jul; 66(1):97-103. PubMed ID: 9209175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.